Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Amlodipine in Obese Patients With Hypertension
NCT03956823Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Aug 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of telmisartan in hypertension (HTN) (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Revascularization for myocardial infarction and unstable angina pectoris at 24 months, Heart failure at 24 months and 1 more. Status: unknown.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03956823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03956823.